Sickle cell anaemia in a changing world.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.Pediatric blood & cancer · 2015
   Trial
2. International dissemination of Brazil's public health system and its technical cooperation initiatives for sickle cell disease, 2006-2010.Historia, ciencias, saude--Manguinhos · 2025
   Article
3. A social profile of deaths related to sickle cell disease in India: a case for an ethical policy response.Frontiers in public health · 2023
   Article
4. Prevalence and factors associated withAfrican health sciences · 2022
   Article

Corrections and comments

• Comment on
  Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions.2013

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as